Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found. The ...

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Blurry vision isn’t always due to screen strain or ageing. Ophthalmologists warn it can signal vitamin deficiencies like A, ...

LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, is advancing its commercialization efforts ...

Paired with external glasses, a tiny chip that is surgically placed under the retina is helping people who are legally blind ...

We’ve been looking at the wrong part of the eye. New research shows the earliest signs of Alzheimer's are hidden at the very edges of the retina.

Spatial computing is expanding from visualization to intelligent systems through AI, IoT, 5G, and cloud convergence. Key opportunities include enhanced real-time decision-making and automation in ...

Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.

Company will debut five-year results from GALE study showing meaningful impact of early and continuous treatment with SYFOVRE® (pegcetacoplan ...